Jonathan Licht and Keith McCrae to lead new Blood specialty journals

CAR T Vision Coalition launches with goal of doubling patients treated with the curative potential of CAR T-cell therapy by 2030

On May 30, an international coalition announced the launch of CAR T Vision, a coalition that aims to unite stakeholders around the shared ambition that every eligible patient should have the opportunity for cure with CAR T-cell therapy.

May 30, 2025

Vol.51 No.21

In Brief

Abu-Rustum, Burt Nabors, Styler, Thompson receive 2025 NCCN awards

Nadeem R. Abu-RustumLouis Burt NaborsMichael J. StylerJames ThompsonErin HeslerNadeem R. Abu-Rustum, Louis Burt Nabors, Michael J. Styler, and James Thompson were recognized by the National Comprehensive Cancer Network as its 2025 awardees who “go above and beyond to define and advance quality, effective, equitable, and accessible cancer care and prevention so all people can live better lives.”

May 30, 2025

Vol.51 No.21

In Brief

Casirati, De Wolf, Persaud, Rehman awarded $260,000 research grants from DKMS

Gabriele Casirati, of Boston Children’s Hospital, Susan E. De Wolf, of Memorial Sloan Kettering Cancer Center, Stephen Persaud, of Washington University School of Medicine, and Abdur Rehman, of the University of Texas MD Anderson Cancer Center, were awarded DKMS’ research grant in honor of John A. Hansen.

April 11, 2025

Vol.51 No.14

In Brief

Nemours opens Lisa Dean Moseley Foundation Institute for Cancer and Blood Disorders

Nemours Children’s Health opened the Lisa Dean Moseley Foundation Institute for Cancer and Blood Disorders, on March 19. The institute is a state-of-the-art facility for pediatric patients in the Delaware Valley and beyond.

March 21, 2025

Vol.51 No.11

In Brief

Megan Melody joins cellular therapies program at Tampa General Hospital

Megan Melody joined the Tampa General Hospital Cancer Institute Cellular Therapy team. She was formerly at the McGaw Medical Center of Northwestern University.

March 07, 2025

Vol.51 No.09

Clinical Roundup

Drug in clinical trials for breast cancer could also treat some blood cancers, studies show

Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.

January 17, 2025

Vol.51 No.02

Jonathan Licht and Keith McCrae to lead new Blood specialty journals

YOU MAY BE INTERESTED IN

CAR T Vision Coalition launches with goal of doubling patients treated with the curative potential of CAR T-cell therapy by 2030

Abu-Rustum, Burt Nabors, Styler, Thompson receive 2025 NCCN awards

Casirati, De Wolf, Persaud, Rehman awarded $260,000 research grants from DKMS

Nemours opens Lisa Dean Moseley Foundation Institute for Cancer and Blood Disorders

Megan Melody joins cellular therapies program at Tampa General Hospital

Drug in clinical trials for breast cancer could also treat some blood cancers, studies show

Renew today!

Subscriber content

Never miss an issue!

Login